How this company, with one of the most advanced compounds for NASH in development today, stellar trial results and very strong science to support the drug's MoA is trading at a $40,000,000 USD market cap is beyond shocking. I think the powers that be are hoping that, if they hold it down long enough, holders will get frustrated and sell lol. Well guess again. I am only accumulating. This is a slap-you-in-the-face buy.
Add to My Watchlist
What is My Watchlist?
